Inactive Instrument

Highlights Celldex Therapeutics, Inc. Nasdaq

Equities

US15117B1035

Highlights

Unlock all the news: Be the first to know and act before the market!

Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria At Eaaci 2024	02/06	CI
Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis	15/05	CI
Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000	07/05	MT
Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Sector Update: Health Care Stocks Mixed Wednesday Afternoon	17/04	MT
Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise	17/04	MT
Celldex Therapeutics, Inc. Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria	17/04	CI
Celldex Therapeutics Shares Rise After Q4 Revenue Tops Estimates	26/02	MT
Celldex Therapeutics Q4 Loss Widens, Revenue Rises; Shares Up Pre-Bell	26/02	MT
Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q4 Revenue $4.1M	26/02	MT
Celldex Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02	CI
Celldex Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26/02	CI
Rate Cut Hopes Push Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday	06/11	MT
Celldex Therapeutics Announces Positive Topline Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria	06/11	CI
Celldex Therapeutics Q3 Net Loss Widens, Revenue Rises	03/11	MT
Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q3 Revenue $1.5M	03/11	MT
Celldex Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11	CI
Celldex Announces Acceptance of Abstract for Barzolvolimab Phase 1B Results in Prurigo Nodularis At 12Th World Congress on Itch 2023	26/23/26	CI
Wall Street tries to stay in the green	22/23/22
Earnings Flash (CLDX) CELLDEX THERAPEUTICS Reports Q2 Revenue $0.3M	09/23/09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Celldex Therapeutics, Inc. Nasdaq

Equities

US15117B1035

Highlights

Filters